Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.72 USD | -0.58% | +2.13% | -8.95% |
05-10 | Pacira BioSciences Prices $250 Million Convertible Senior Notes Offering | MT |
05-08 | Needham Adjusts Price Target on Pacira BioSciences to $43 From $45, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.95% | 1.43B | |
+37.74% | 723B | |
+34.67% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+17.04% | 244B | |
+10.04% | 208B | |
-4.21% | 205B | |
+7.43% | 166B |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- Earnings Flash (PCRX) PACIRA BIOSCIENCES Posts Q2 EPS $0.78, vs. Street Est of $0.76